Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial

The Lancet ◽  
2021 ◽  
Author(s):  
Enriqueta Felip ◽  
Nasser Altorki ◽  
Caicun Zhou ◽  
Tibor Csőszi ◽  
Ihor Vynnychenko ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Adjuvant Chemotherapy ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Open Label ◽  
Phase 3 ◽  
Open Label Phase ◽  
Resected Stage

scholarly journals Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial

2017 ◽  
Vol 18 (12) ◽  
pp. 1610-1623 ◽  
Author(s):  
Heather A Wakelee ◽  
Suzanne E Dahlberg ◽  
Steven M Keller ◽  
William J Tester ◽  
David R Gandara ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Adjuvant Chemotherapy ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Open Label ◽  
Phase 3
Sign in / Sign up

Export Citation Format

Share Document